Home/Filings/4/0001127602-25-019583
4//SEC Filing

Gillen Sean M. 4

Accession 0001127602-25-019583

CIK 0000001750other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 2:46 PM ET

Size

34.6 KB

Accession

0001127602-25-019583

Insider Transaction Report

Form 4
Period: 2025-07-23
Gillen Sean M.
Senior VP-CFO
Transactions
  • Sale

    Common Stock

    2025-07-23$77.37/sh2,000$154,74899,868.203 total
  • Exercise/Conversion

    Stock Option

    2025-07-238,00039,870 total
    Exercise: $18.94From: 2021-07-31Exp: 2030-07-13Common Stock (8,000 underlying)
  • Sale

    Common Stock

    2025-07-23$77.37/sh8,000$618,99299,868.203 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$41.88/sh+4,000$167,520103,868.203 total
  • Sale

    Common Stock

    2025-07-23$77.37/sh4,000$309,49699,868.203 total
  • Sale

    Common Stock

    2025-07-23$77.37/sh4,000$309,49699,868.203 total
  • Award

    Stock Option

    2025-07-23+10,55010,550 total
    Exercise: $79.45From: 2026-07-31Exp: 2035-07-23Common Stock (10,550 underlying)
  • Exercise/Conversion

    Stock Option

    2025-07-234,0003,970 total
    Exercise: $37.74From: 2022-07-31Exp: 2031-07-12Common Stock (4,000 underlying)
  • Exercise/Conversion

    Stock Option

    2025-07-234,0008,065 total
    Exercise: $41.88From: 2023-07-31Exp: 2032-07-18Common Stock (4,000 underlying)
  • Award

    Common Stock

    2025-07-23+3,81588,423.203 total
  • Award

    Common Stock

    2025-07-23+11,44599,868.203 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$18.94/sh+8,000$151,520107,868.203 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$37.74/sh+4,000$150,960103,868.203 total
  • Exercise/Conversion

    Common Stock

    2025-07-23$58.27/sh+2,000$116,540101,868.203 total
  • Exercise/Conversion

    Stock Option

    2025-07-232,0004,715 total
    Exercise: $58.27From: 2024-07-31Exp: 2033-07-24Common Stock (2,000 underlying)
Footnotes (8)
  • [F1]Award of stock pursuant to a Restricted Stock Agreement in a transaction exempt under Rule 16b-3.
  • [F2]Award of stock pursuant to a Performance Restricted Stock Agreement in a transaction exempt under Rule 16b-3.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.43 to $79.16 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2026 and shall vest as follows: 33 and 1/3% on each of July 31, 2026, July 31, 2027 and July 31, 2028.
  • [F5]The awarded stock option vested and became exercisable in 1/3 annual installments beginning on July 31, 2021 and vested as follows: 33 and 1/3% on each of July 31, 2021, July 31, 2022 and July 31, 2023.
  • [F6]The awarded stock option vested and became exercisable in 1/3 annual installments beginning on July 31, 2022 and vested as follows: 33 and 1/3% on each of July 31, 2022, July 31, 2023 and July 31, 2024.
  • [F7]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2023 and shall vest as follows: 33 and 1/3% on each of July 31, 2023, July 31, 2024 and July 31, 2025.
  • [F8]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2024 and shall vest as follows: 33 and 1/3% on each of July 31, 2024, July 31, 2025, and July 31, 2026.

Issuer

AAR CORP

CIK 0000001750

Entity typeother

Related Parties

1
  • filerCIK 0001764537

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 2:46 PM ET
Size
34.6 KB